P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000844268.82216.4a |
| _version_ | 1797281744502652928 |
|---|---|
| author | P. Stachura W. Liu A. Wlodarczyk C. Xu S. Bhatia P. A. Lang A. Borkhardt A. A. Pandyra |
| author_facet | P. Stachura W. Liu A. Wlodarczyk C. Xu S. Bhatia P. A. Lang A. Borkhardt A. A. Pandyra |
| author_sort | P. Stachura |
| collection | DOAJ |
| first_indexed | 2024-03-07T17:01:52Z |
| format | Article |
| id | doaj.art-576125738bc44352b016eb25862863cd |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T17:01:52Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-576125738bc44352b016eb25862863cd2024-03-03T03:19:22ZengWileyHemaSphere2572-92412022-06-01624524610.1097/01.HS9.0000844268.82216.4a202206003-00245P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPYP. Stachura0W. Liu1A. Wlodarczyk2C. Xu3S. Bhatia4P. A. Lang5A. Borkhardt6A. A. Pandyra71 Department of Molecular Medicine II1 Department of Molecular Medicine II2 Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University Dusseldorf1 Department of Molecular Medicine II2 Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University Dusseldorf1 Department of Molecular Medicine II2 Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University Dusseldorf2 Department of Pediatric Oncology, Hematology and Clinical Immunology, Heinrich-Heine-University Dusseldorfhttp://journals.lww.com/10.1097/01.HS9.0000844268.82216.4a |
| spellingShingle | P. Stachura W. Liu A. Wlodarczyk C. Xu S. Bhatia P. A. Lang A. Borkhardt A. A. Pandyra P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY HemaSphere |
| title | P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY |
| title_full | P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY |
| title_fullStr | P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY |
| title_full_unstemmed | P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY |
| title_short | P345: AN IMMUNE SCREEN IDENTIFIES 5-NONLOXYTRYPTAMINE AS A NOVEL ANTI-CANCER AGENT CAPABLE OF IMPROVING ANTI-TUMOR IMMUNITY IN COMBINATION WITH ANTI-PD1 THERAPY |
| title_sort | p345 an immune screen identifies 5 nonloxytryptamine as a novel anti cancer agent capable of improving anti tumor immunity in combination with anti pd1 therapy |
| url | http://journals.lww.com/10.1097/01.HS9.0000844268.82216.4a |
| work_keys_str_mv | AT pstachura p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT wliu p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT awlodarczyk p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT cxu p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT sbhatia p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT palang p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT aborkhardt p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy AT aapandyra p345animmunescreenidentifies5nonloxytryptamineasanovelanticanceragentcapableofimprovingantitumorimmunityincombinationwithantipd1therapy |